CRISPR Therapeutics AG (CRSP)
56.88
-1.30
(-2.23%)
USD |
NASDAQ |
Dec 05, 16:00
56.95
+0.07
(+0.12%)
After-Hours: 20:00
CRISPR Therapeutics Total Liabilities (Quarterly): 329.33M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 7.544B |
| Intellia Therapeutics, Inc. | 176.85M |
| Novartis AG | 62.54B |
| Beam Therapeutics, Inc. | 345.08M |
| BeOne Medicines Ltd. | 3.474B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.245B |
| Shareholders Equity (Quarterly) | 1.916B |
| Debt to Equity Ratio | 0.1101 |
| Current Ratio | 16.22 |
| Net Debt Paydown Yield | 0.07% |